You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Guérin (BCG)
Journal for Immunotherapy of Cancer, January 2015
Gary Steinberg, Neal Shore, Lawrence Karsh, James Bailen, Michael Woods, Taylor Schreiber, Melissa Price
The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Ph. D. Student||1||17%|
|Student > Doctoral Student||1||17%|
|Readers by discipline||Count||As %|
|Immunology and Microbiology||2||33%|
|Medicine and Dentistry||2||33%|